Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/n8vbnd/lyophilized) has announced the addition of the "Lyophilized Injectables to 2020" report to their offering.
The inherent instability of protein drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a requirement referred to as the cold chain'. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection.
What You Will Learn
- Provides detailed analysis of lyophilized drugs, as-supplied packaging and therapeutic indication
- Analyzes therapeutic demand drivers and evaluates lyophilized drugs in eleven therapeutic areas
- Analyzes lyophilization technologies and market development issues
- Provides market data and forecasts to 2020
- Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
- Assesses the importance of technology and regulatory factors on commercialization and market access
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
- Delivery Market Dynamics
- The Economics of lyophilized Drugs
- What's Driving the Market for Lyophilized Drugs?
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
3. Lyophilized Drugs - Primary Packaging
- Single Use Vials
- Point-of-Care Reconstitution
- Specialty Packaging
- Drugs for SC/IM Injection
- Drugs for Infusion
- Product Specific Devices
4. Lyophilized Drugs - Reconstitution and Delivery
- Prefilled Diluent Syringes
- Proprietary Reconstitution Devices
- Single Step Devices
- Multi-Step Devices
- Human Engineering/Ergonomics
5. Lyophilized Drugs - Key Therapeutic Sector Analysis and Market Data
- Antibiotics
- Autoimmune Diseases
- Blood Factors
- Hormones
- Infectious Diseases
- Metabolic Conditions
- Oncology
- Reproductive Health
- Other Important Therapeutic Classes
6. Market Factors
- Regulatory Issues
- Patient Compliance and Ease of Use
- Healthcare Economics
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/n8vbnd/lyophilized
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



